Epigenetics Market to reach $4.1 billion by 2030, growing at a CAGR of 14.8% from 2021 to 2030 | Active Motif, Inc., PerkinElmer, Inc., Zymo Research, Merck Millipore

Rise in cancer prevalence; increase in funding & aids for R&D activities; rise in partnership between academic, pharmaceutical, & biotechnology companies for epigenetics studies; and increase in application of epigenetics in non-oncology diseases majorly drives the market growth. In addition, various product launch, collaborations, and other developmental strategies among key players further drive the market.

According to the report published by Allied Market Research, the global epigenetics market was estimated at $1.0 billion in 2020 and is expected to hit $4.1 billion by 2030, registering a CAGR of 14.8% from 2021 to 2030.

For Right Perspective, Download Sample PDF at:

https://www.alliedmarketresearch.com/request-sample/846

Drivers, restraints, and opportunities:

High-end technological advancements associated with epigenetics, rise in incidences of cancer, surge in genome mapping programs, and growing number of R&D activities drive the global epigenetics market. On the other hand, standardization concerns over epigenetics-based diagnostics and dearth of skilled professionals impede the growth to some extent. However, several growth opportunities in the emerging economies have created an array of lucrative prospects for the key players in the industry.

Topics discussed in the report:

DNA Methylation
Next-Generation Sequencing (NGS)
Autoimmune Diseases
Epigenetics as collectibles
Precision Medicine
Clinical Trials in Epigenetics
Regulatory Challenges in Epigenetics

Segment Overview:

The epigenetics market is divided by product, application, end user, and region. By product the market is classified into reagents, enzymes, instruments, and kits. By application, the market is divided into oncology and non-oncology. According to the end user, the market is divided into academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and contract research organizations. By region, the market is divided into North America (the U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Middle East and Africa, Latin America).

Comparative Matrix of Key Segments:

By Product:

Reagents
Enzymes
Instruments
Kits

By Application:

Oncology
Non Oncology

By End User:

Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Contrac Research Organizations

By Region:

North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
LAMEA (Middle East And Africa, Latin America)

Ask to Our Industry Expert:

https://www.alliedmarketresearch.com/purchase-enquiry/846

North America held the major share in 2020-

By region, the market across North America dominated in 2020, garnering nearly of the global epigenetics market, owing to rapid adoption of advanced technologies and presence of key players across North America. Simultaneously, Asia-Pacific is expected to cite the fastest CAGR of 16.3% throughout the forecast period, due to rise in R & D activities for epigenetics services and increase in healthcare investment in the region.

Key players in the industry-

Abcam Plc.
PerkinElmer, Inc.
Zymo Research
QIAGEN N.V.
Merck Millipore
Agilent Technologies, Inc.
Illumina Inc.
Active Motif, Inc.
Hologic Inc.
Thermo Fisher Scientific Inc.

Contact:

David Correa

1209 Orange Street,

Corporation Trust Center,

Wilmington, New Castle,

Delaware 19801 USA.

Toll Free: +1-800-792-5285

Int'l: +1-503-894-6022

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1-855-550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.